Phase I Study of Intravenous Artesunate for Solid Tumors
NCT02353026
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Intravenous Artesunate
Sponsor
Georgetown University
Collaborators
[object Object]